Medication info

Multitrace Injection

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCopper Sulfate›1.57mg / 1mLManganese Sulfate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
A colorless and transparent vial injection containing a colorless, transparent, or slightly blue transparent liquid
Packaging
10mL × 10 vials, 20mL × 10 vials
Approval status
Active

MFDS item code 201604139 · Notified 2016.07.04

Summary

Main use
Prevention of trace element deficiencies (zinc, copper, manganese, etc.) during intravenous nutritional support
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, and check plasma trace element levels to guide dose adjustment. Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4 mg daily Copper: 0.5∼1.5 mg daily Manganese: 0.15∼0.8 mg daily Chromium: 10∼15 μg daily Selenium: 20∼40 μg daily Patients with small intestinal fluid loss who are metabolically stable: additionally, 12.2 mg/L (amount of small intestinal fluid lost) or 17.1 mg/kg (amount of stool) Patients with acute catabolic conditions: 4.5∼6 mg daily Patients with small intestinal fluid loss who are metabolically stable: 20 μg daily Deficiency due to long-term parenteral nutrition: 100 μg daily may be used for 24∼31 days.
Child administration
Children 5 years or younger: zinc 100 μg/kg body weight daily, copper 20 μg/kg body weight daily, manganese 2∼10 μg/kg body weight daily, chromium 0.14∼0.20 μg/kg body weight daily, selenium 3 μg/kg body weight daily

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Prevention of trace element deficiencies (zinc, copper, manganese, etc.) during intravenous nutritional support

View approved original text

Adequate supply of trace elements such as zinc, copper, manganese, selenium, and chromium during intravenous nutrition is essential for maintaining the balance of essential minerals in the body, supporting metabolism and immune function. These trace elements aid in wound healing and cellular function, promoting recovery in patients. Therefore, this trace element supply is used to prevent nutritional imbalances and improve overall health.

How it is given

Adult administration

Use as prescribed by a physician, and check plasma trace element levels to guide dose adjustment. Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4 mg daily Copper: 0.5∼1.5 mg daily Manganese: 0.15∼0.8 mg daily Chromium: 10∼15 μg daily Selenium: 20∼40 μg daily Patients with small intestinal fluid loss who are metabolically stable: additionally, 12.2 mg/L (amount of small intestinal fluid lost) or 17.1 mg/kg (amount of stool) Patients with acute catabolic conditions: 4.5∼6 mg daily Patients with small intestinal fluid loss who are metabolically stable: 20 μg daily Deficiency due to long-term parenteral nutrition: 100 μg daily may be used for 24∼31 days.

Child administration

Children 5 years or younger: zinc 100 μg/kg body weight daily, copper 20 μg/kg body weight daily, manganese 2∼10 μg/kg body weight daily, chromium 0.14∼0.20 μg/kg body weight daily, selenium 3 μg/kg body weight daily

Precautions

This medication should not be administered to premature infants and neonates due to the inclusion of benzyl alcohol, which may cause fatal respiratory issues in these age groups. Injecting without dilution directly into the vein may cause phlebitis; therefore, it must always be diluted before use. This medication is a hypotonic solution, so it should only be used for mixed injections, and it is safer not to administer it alone. If any component shows toxic symptoms during administration, the infusion should be stopped immediately. Parenteral nutrition solutions contain aluminum, which may exhibit toxicity if administered for a long period in patients with impaired kidney function or preterm infants. Physicians should accurately assess the patient's condition and metabolic requirements to adjust doses and should frequently monitor serum levels of trace elements. In patients with renal failure, there is a risk of zinc accumulation, and in patients with biliary obstruction, copper and manganese may accumulate in the body, requiring caution. Diabetes patients should verify the use of diabetes medications since chromium may affect blood sugar control. Selenium dose should be adjusted for patients with renal and gastrointestinal dysfunction, and in blood transfusion patients, the effects of transfusion should be taken into account. The safety of this medication during pregnancy is not established, thus it should only be administered when treatment benefits outweigh risks in pregnant women or women of childbearing potential. Overdosage may cause toxic symptoms of zinc, copper, chromium, selenium, etc., so strict adherence to prescribed dosages is necessary, and if toxicity symptoms are suspected, notify medical personnel immediately. Before administration, confirm the absence of discoloration or foreign substances in the solution and handle under aseptic conditions to minimize infection risk. This medication should be stored in a sealed container to protect from air and moisture. It should be kept in a dry place at room temperature between 15 to 30 degrees Celsius. This helps maintain the drug's efficacy and safety.

Side effects

  • Shortness of breath
  • sweating
  • decreased consciousness
  • blurred vision
  • tachycardia
  • hypothermia
  • hypotension
  • pulmonary edema
  • diarrhea
  • vomiting
Show 30 more
  • jaundice
  • decreased urine output
  • weakness
  • behavioral changes
  • progressive wasting syndrome
  • glare
  • peripheral edema
  • nausea
  • ulcers
  • gastrointestinal disturbances
  • renal impairment
  • liver impairment
  • seizures
  • coma
  • hair loss
  • nail weakness
  • dermatitis
  • dental damage
  • irritability
  • depression
  • metallic taste
  • sweating
  • garlic smell during respiration
  • acute peripheral vascular collapse
  • vascular congestion
  • pulmonary hemorrhage
  • pulmonary congestion
  • pulmonary edema
  • gastric mucosal discoloration
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture intrusion. The recommended storage temperature is to maintain room temperature between 15 and 30 degrees Celsius. This helps ensure the drug's efficacy and safety.

Appearance and packaging

Appearance

A colorless and transparent vial injection containing a colorless, transparent, or slightly blue transparent liquid

Package unit

10mL × 10 vials, 20mL × 10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.